APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antidiabetic Sulphonylureas

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Antidiabetic Sulphonylureas Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025195 pages

Choose your research edition.

Industry ResearchAntidiabetic Sulphonylureas Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Antidiabetic Sulphonylureas Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Antidiabetic Sulphonylureas Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antidiabetic Sulphonylureas Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Antidiabetic Sulphonylureas Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Antidiabetic Sulphonylureas market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Antidiabetic Sulphonylureas is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antidiabetic Sulphonylureas is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antidiabetic Sulphonylureas is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Antidiabetic Sulphonylureas is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antidiabetic Sulphonylureas include Boehringer Ingelheim, Bristol-Myers Squibb, Novo Nordisk, Servier Laboratories, AstraZeneca, GlaxoSmithKline, Pfizer, Eli Lilly and Merck & Co, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Antidiabetic Sulphonylureas market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antidiabetic Sulphonylureas and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antidiabetic Sulphonylureas sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Antidiabetic Sulphonylureas market size, projected growth trends, production technologies, key applications, and end-use industries.

Antidiabetic Sulphonylureas Segment by Company

Boehringer Ingelheim

Bristol-Myers Squibb

Novo Nordisk

Servier Laboratories

AstraZeneca

GlaxoSmithKline

Pfizer

Eli Lilly

Merck & Co

Sanofi

Takeda Pharmaceuticals

Antidiabetic Sulphonylureas Segment by Type

First Generation Antidiabetic Sulphonylureas

The Second Generation Antidiabetic Sulphonylureas

The Third Generation Antidiabetic Sulphonylureas

Antidiabetic Sulphonylureas Segment by Application

Hospitals

Clinics

Other

Antidiabetic Sulphonylureas Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antidiabetic Sulphonylureas market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antidiabetic Sulphonylureas and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antidiabetic Sulphonylureas.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Antidiabetic Sulphonylureas market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antidiabetic Sulphonylureas manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Antidiabetic Sulphonylureas in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Antidiabetic Sulphonylureas in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Antidiabetic Sulphonylureas Industry Trends Table 2. Antidiabetic Sulphonylureas Industry Drivers Table 3. Antidiabetic Sulphonylureas Industry Opportunities and Challenges Table 4. Antidiabetic Sulphonylureas Industry Restraints Table 5. Global Antidiabetic Sulphonylureas Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Antidiabetic Sulphonylureas Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Antidiabetic Sulphonylureas Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Antidiabetic Sulphonylureas Sales Market Share by Manufacturers Table 9. Global Antidiabetic Sulphonylureas Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Antidiabetic Sulphonylureas Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Antidiabetic Sulphonylureas Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Antidiabetic Sulphonylureas Manufacturers, Product Type & Application Table 13. Global Antidiabetic Sulphonylureas Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Antidiabetic Sulphonylureas by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of First Generation Antidiabetic Sulphonylureas Table 17. Major Manufacturers of The Second Generation Antidiabetic Sulphonylureas Table 18. Major Manufacturers of The Third Generation Antidiabetic Sulphonylureas Table 19. Global Antidiabetic Sulphonylureas Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Antidiabetic Sulphonylureas Sales by Type (2021-2026) & (K Units) Table 21. Global Antidiabetic Sulphonylureas Sales by Type (2027-2032) & (K Units) Table 22. Global Antidiabetic Sulphonylureas Sales Market Share by Type (2021-2026) Table 23. Global Antidiabetic Sulphonylureas Sales Market Share by Type (2027-2032) Table 24. Global Antidiabetic Sulphonylureas Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Antidiabetic Sulphonylureas Revenue by Type (2021-2026) & (K Units) Table 26. Global Antidiabetic Sulphonylureas Revenue by Type (2027-2032) & (K Units) Table 27. Global Antidiabetic Sulphonylureas Revenue Market Share by Type (2021-2026) Table 28. Global Antidiabetic Sulphonylureas Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospitals Table 30. Major Manufacturers of Clinics Table 31. Major Manufacturers of Other Table 32. Global Antidiabetic Sulphonylureas Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Antidiabetic Sulphonylureas Sales by Application (2021-2026) & (K Units) Table 34. Global Antidiabetic Sulphonylureas Sales by Application (2027-2032) & (K Units) Table 35. Global Antidiabetic Sulphonylureas Sales Market Share by Application (2021-2026) Table 36. Global Antidiabetic Sulphonylureas Sales Market Share by Application (2027-2032) Table 37. Global Antidiabetic Sulphonylureas Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Antidiabetic Sulphonylureas Revenue by Application (2021-2026) & (K Units) Table 39. Global Antidiabetic Sulphonylureas Revenue by Application (2027-2032) & (K Units) Table 40. Global Antidiabetic Sulphonylureas Revenue Market Share by Application (2021-2026) Table 41. Global Antidiabetic Sulphonylureas Revenue Market Share by Application (2027-2032) Table 42. Global Antidiabetic Sulphonylureas Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Antidiabetic Sulphonylureas Sales by Region (2021-2026) & (K Units) Table 44. Global Antidiabetic Sulphonylureas Sales Market Share by Region (2021-2026) Table 45. Global Antidiabetic Sulphonylureas Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Antidiabetic Sulphonylureas Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Antidiabetic Sulphonylureas Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Antidiabetic Sulphonylureas Sales by Country (2021-2026) & (K Units) Table 49. North America Antidiabetic Sulphonylureas Sales by Country (2027-2032) & (K Units) Table 50. Europe Antidiabetic Sulphonylureas Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Antidiabetic Sulphonylureas Sales by Country (2021-2026) & (K Units) Table 52. Europe Antidiabetic Sulphonylureas Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Antidiabetic Sulphonylureas Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Antidiabetic Sulphonylureas Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Antidiabetic Sulphonylureas Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Antidiabetic Sulphonylureas Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Antidiabetic Sulphonylureas Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Antidiabetic Sulphonylureas Sales by Country (2027-2032) & (K Units) Table 59. Global Antidiabetic Sulphonylureas Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Antidiabetic Sulphonylureas Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Antidiabetic Sulphonylureas Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Antidiabetic Sulphonylureas Revenue Market Share by Region (2021-2026) Table 63. Global Antidiabetic Sulphonylureas Revenue Market Share by Region (2027-2032) Table 64. Boehringer Ingelheim Company Information Table 65. Boehringer Ingelheim Business Overview Table 66. Boehringer Ingelheim Antidiabetic Sulphonylureas Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Boehringer Ingelheim Antidiabetic Sulphonylureas Product Portfolio Table 68. Boehringer Ingelheim Recent Development Table 69. Bristol-Myers Squibb Company Information Table 70. Bristol-Myers Squibb Business Overview Table 71. Bristol-Myers Squibb Antidiabetic Sulphonylureas Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Bristol-Myers Squibb Antidiabetic Sulphonylureas Product Portfolio Table 73. Bristol-Myers Squibb Recent Development Table 74. Novo Nordisk Company Information Table 75. Novo Nordisk Business Overview Table 76. Novo Nordisk Antidiabetic Sulphonylureas Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Novo Nordisk Antidiabetic Sulphonylureas Product Portfolio Table 78. Novo Nordisk Recent Development Table 79. Servier Laboratories Company Information Table 80. Servier Laboratories Business Overview Table 81. Servier Laboratories Antidiabetic Sulphonylureas Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Servier Laboratories Antidiabetic Sulphonylureas Product Portfolio Table 83. Servier Laboratories Recent Development Table 84. AstraZeneca Company Information Table 85. AstraZeneca Business Overview Table 86. AstraZeneca Antidiabetic Sulphonylureas Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. AstraZeneca Antidiabetic Sulphonylureas Product Portfolio Table 88. AstraZeneca Recent Development Table 89. GlaxoSmithKline Company Information Table 90. GlaxoSmithKline Business Overview Table 91. GlaxoSmithKline Antidiabetic Sulphonylureas Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. GlaxoSmithKline Antidiabetic Sulphonylureas Product Portfolio Table 93. GlaxoSmithKline Recent Development Table 94. Pfizer Company Information Table 95. Pfizer Business Overview Table 96. Pfizer Antidiabetic Sulphonylureas Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Pfizer Antidiabetic Sulphonylureas Product Portfolio Table 98. Pfizer Recent Development Table 99. Eli Lilly Company Information Table 100. Eli Lilly Business Overview Table 101. Eli Lilly Antidiabetic Sulphonylureas Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Eli Lilly Antidiabetic Sulphonylureas Product Portfolio Table 103. Eli Lilly Recent Development Table 104. Merck & Co Company Information Table 105. Merck & Co Business Overview Table 106. Merck & Co Antidiabetic Sulphonylureas Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Merck & Co Antidiabetic Sulphonylureas Product Portfolio Table 108. Merck & Co Recent Development Table 109. Sanofi Company Information Table 110. Sanofi Business Overview Table 111. Sanofi Antidiabetic Sulphonylureas Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Sanofi Antidiabetic Sulphonylureas Product Portfolio Table 113. Sanofi Recent Development Table 114. Takeda Pharmaceuticals Company Information Table 115. Takeda Pharmaceuticals Business Overview Table 116. Takeda Pharmaceuticals Antidiabetic Sulphonylureas Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Takeda Pharmaceuticals Antidiabetic Sulphonylureas Product Portfolio Table 118. Takeda Pharmaceuticals Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. Antidiabetic Sulphonylureas Distributors List Table 122. Antidiabetic Sulphonylureas Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Antidiabetic Sulphonylureas Product Image Figure 2. Global Antidiabetic Sulphonylureas Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antidiabetic Sulphonylureas Market Size (2021-2032) & (US$ Million) Figure 4. Global Antidiabetic Sulphonylureas Sales (2021-2032) & (K Units) Figure 5. Global Antidiabetic Sulphonylureas Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Antidiabetic Sulphonylureas Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. First Generation Antidiabetic Sulphonylureas Image Figure 9. The Second Generation Antidiabetic Sulphonylureas Image Figure 10. The Third Generation Antidiabetic Sulphonylureas Image Figure 11. Global Antidiabetic Sulphonylureas Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Antidiabetic Sulphonylureas Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Antidiabetic Sulphonylureas Sales Market Share by Type (2021-2032) Figure 14. Global Antidiabetic Sulphonylureas Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Antidiabetic Sulphonylureas Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Antidiabetic Sulphonylureas Revenue Market Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Clinics Image Figure 19. Other Image Figure 20. Global Antidiabetic Sulphonylureas Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Antidiabetic Sulphonylureas Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Antidiabetic Sulphonylureas Sales Market Share by Application (2021-2032) Figure 23. Global Antidiabetic Sulphonylureas Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Antidiabetic Sulphonylureas Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Antidiabetic Sulphonylureas Revenue Market Share by Application (2021-2032) Figure 26. North America Antidiabetic Sulphonylureas Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Antidiabetic Sulphonylureas Sales Market Share by Country (2021-2032) Figure 28. U.S. Antidiabetic Sulphonylureas Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Antidiabetic Sulphonylureas Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Antidiabetic Sulphonylureas Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Antidiabetic Sulphonylureas Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Antidiabetic Sulphonylureas Sales Market Share by Country (2021-2032) Figure 33. Germany Antidiabetic Sulphonylureas Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Antidiabetic Sulphonylureas Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Antidiabetic Sulphonylureas Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Antidiabetic Sulphonylureas Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Antidiabetic Sulphonylureas Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Antidiabetic Sulphonylureas Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Antidiabetic Sulphonylureas Sales Market Share by Country (2021-2032) Figure 40. China Antidiabetic Sulphonylureas Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Antidiabetic Sulphonylureas Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Antidiabetic Sulphonylureas Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Antidiabetic Sulphonylureas Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Antidiabetic Sulphonylureas Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Antidiabetic Sulphonylureas Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Antidiabetic Sulphonylureas Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Antidiabetic Sulphonylureas Sales Market Share by Country (2021-2032) Figure 48. Brazil Antidiabetic Sulphonylureas Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Antidiabetic Sulphonylureas Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Antidiabetic Sulphonylureas Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Antidiabetic Sulphonylureas Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Antidiabetic Sulphonylureas Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Antidiabetic Sulphonylureas Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Antidiabetic Sulphonylureas Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Antidiabetic Sulphonylureas Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Antidiabetic Sulphonylureas Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Antidiabetic Sulphonylureas Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Antidiabetic Sulphonylureas Revenue (2021-2032) & (US$ Million) Figure 59. North America Antidiabetic Sulphonylureas Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Antidiabetic Sulphonylureas Revenue (2021-2032) & (US$ Million) Figure 61. Europe Antidiabetic Sulphonylureas Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Antidiabetic Sulphonylureas Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Antidiabetic Sulphonylureas Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Antidiabetic Sulphonylureas Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Antidiabetic Sulphonylureas Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Antidiabetic Sulphonylureas Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Antidiabetic Sulphonylureas Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • First Generation Antidiabetic Sulphonylureas
  • The Second Generation Antidiabetic Sulphonylureas
  • The Third Generation Antidiabetic Sulphonylureas
Applications
  • Hospitals
  • Clinics
  • Other
Companies covered
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Novo Nordisk
  • Servier Laboratories
  • AstraZeneca
  • GlaxoSmithKline
  • Pfizer
  • Eli Lilly
  • Merck & Co
  • Sanofi
  • Takeda Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Antidiabetic Sulphonylureas Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Antidiabetic Sulphonylureas Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Antidiabetic Sulphonylureas Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Antidiabetic Sulphonylureas Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Antidiabetic Sulphonylureas Market Dynamics
  1. 2.1 Antidiabetic Sulphonylureas Industry Trends
  2. 2.2 Antidiabetic Sulphonylureas Industry Drivers
  3. 2.3 Antidiabetic Sulphonylureas Industry Opportunities and Challenges
  4. 2.4 Antidiabetic Sulphonylureas Industry Restraints
3 Antidiabetic Sulphonylureas Market by Manufacturers
  1. 3.1 Global Antidiabetic Sulphonylureas Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Antidiabetic Sulphonylureas Sales by Manufacturers (2021-2026)
  3. 3.3 Global Antidiabetic Sulphonylureas Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Antidiabetic Sulphonylureas Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antidiabetic Sulphonylureas Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Antidiabetic Sulphonylureas Manufacturers, Product Type & Application
  7. 3.7 Global Antidiabetic Sulphonylureas Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antidiabetic Sulphonylureas Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antidiabetic Sulphonylureas Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antidiabetic Sulphonylureas Tier 1, Tier 2, and Tier 3
4 Antidiabetic Sulphonylureas Market by Type
  1. 4.1 Antidiabetic Sulphonylureas Type Introduction
  2. 4.1.1 First Generation Antidiabetic Sulphonylureas
  3. 4.1.2 The Second Generation Antidiabetic Sulphonylureas
  4. 4.1.3 The Third Generation Antidiabetic Sulphonylureas
  5. 4.2 Global Antidiabetic Sulphonylureas Sales by Type
  6. 4.2.1 Global Antidiabetic Sulphonylureas Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Antidiabetic Sulphonylureas Sales by Type (2021-2032)
  8. 4.2.3 Global Antidiabetic Sulphonylureas Sales Market Share by Type (2021-2032)
  9. 4.3 Global Antidiabetic Sulphonylureas Revenue by Type
  10. 4.3.1 Global Antidiabetic Sulphonylureas Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Antidiabetic Sulphonylureas Revenue by Type (2021-2032)
  12. 4.3.3 Global Antidiabetic Sulphonylureas Revenue Market Share by Type (2021-2032)
5 Antidiabetic Sulphonylureas Market by Application
  1. 5.1 Antidiabetic Sulphonylureas Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Other
  5. 5.2 Global Antidiabetic Sulphonylureas Sales by Application
  6. 5.2.1 Global Antidiabetic Sulphonylureas Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Antidiabetic Sulphonylureas Sales by Application (2021-2032)
  8. 5.2.3 Global Antidiabetic Sulphonylureas Sales Market Share by Application (2021-2032)
  9. 5.3 Global Antidiabetic Sulphonylureas Revenue by Application
  10. 5.3.1 Global Antidiabetic Sulphonylureas Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Antidiabetic Sulphonylureas Revenue by Application (2021-2032)
  12. 5.3.3 Global Antidiabetic Sulphonylureas Revenue Market Share by Application (2021-2032)
6 Global Antidiabetic Sulphonylureas Sales by Region
  1. 6.1 Global Antidiabetic Sulphonylureas Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antidiabetic Sulphonylureas Sales by Region (2021-2032)
  3. 6.2.1 Global Antidiabetic Sulphonylureas Sales by Region (2021-2026)
  4. 6.2.2 Global Antidiabetic Sulphonylureas Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Antidiabetic Sulphonylureas Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Antidiabetic Sulphonylureas Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Antidiabetic Sulphonylureas Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Antidiabetic Sulphonylureas Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Antidiabetic Sulphonylureas Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Antidiabetic Sulphonylureas Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Antidiabetic Sulphonylureas Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Antidiabetic Sulphonylureas Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Antidiabetic Sulphonylureas Revenue by Region
  1. 7.1 Global Antidiabetic Sulphonylureas Revenue by Region
  2. 7.1.1 Global Antidiabetic Sulphonylureas Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Antidiabetic Sulphonylureas Revenue by Region (2021-2026)
  4. 7.1.3 Global Antidiabetic Sulphonylureas Revenue by Region (2027-2032)
  5. 7.1.4 Global Antidiabetic Sulphonylureas Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Antidiabetic Sulphonylureas Revenue (2021-2032)
  8. 7.2.2 North America Antidiabetic Sulphonylureas Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Antidiabetic Sulphonylureas Revenue (2021-2032)
  11. 7.3.2 Europe Antidiabetic Sulphonylureas Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Antidiabetic Sulphonylureas Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Antidiabetic Sulphonylureas Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Antidiabetic Sulphonylureas Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Antidiabetic Sulphonylureas Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Boehringer Ingelheim
  2. 8.1.1 Boehringer Ingelheim Company Information
  3. 8.1.2 Boehringer Ingelheim Business Overview
  4. 8.1.3 Boehringer Ingelheim Antidiabetic Sulphonylureas Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Boehringer Ingelheim Antidiabetic Sulphonylureas Product Portfolio
  6. 8.1.5 Boehringer Ingelheim Recent Developments
  7. 8.2 Bristol-Myers Squibb
  8. 8.2.1 Bristol-Myers Squibb Company Information
  9. 8.2.2 Bristol-Myers Squibb Business Overview
  10. 8.2.3 Bristol-Myers Squibb Antidiabetic Sulphonylureas Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bristol-Myers Squibb Antidiabetic Sulphonylureas Product Portfolio
  12. 8.2.5 Bristol-Myers Squibb Recent Developments
  13. 8.3 Novo Nordisk
  14. 8.3.1 Novo Nordisk Company Information
  15. 8.3.2 Novo Nordisk Business Overview
  16. 8.3.3 Novo Nordisk Antidiabetic Sulphonylureas Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novo Nordisk Antidiabetic Sulphonylureas Product Portfolio
  18. 8.3.5 Novo Nordisk Recent Developments
  19. 8.4 Servier Laboratories
  20. 8.4.1 Servier Laboratories Company Information
  21. 8.4.2 Servier Laboratories Business Overview
  22. 8.4.3 Servier Laboratories Antidiabetic Sulphonylureas Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Servier Laboratories Antidiabetic Sulphonylureas Product Portfolio
  24. 8.4.5 Servier Laboratories Recent Developments
  25. 8.5 AstraZeneca
  26. 8.5.1 AstraZeneca Company Information
  27. 8.5.2 AstraZeneca Business Overview
  28. 8.5.3 AstraZeneca Antidiabetic Sulphonylureas Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 AstraZeneca Antidiabetic Sulphonylureas Product Portfolio
  30. 8.5.5 AstraZeneca Recent Developments
  31. 8.6 GlaxoSmithKline
  32. 8.6.1 GlaxoSmithKline Company Information
  33. 8.6.2 GlaxoSmithKline Business Overview
  34. 8.6.3 GlaxoSmithKline Antidiabetic Sulphonylureas Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GlaxoSmithKline Antidiabetic Sulphonylureas Product Portfolio
  36. 8.6.5 GlaxoSmithKline Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer Antidiabetic Sulphonylureas Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Antidiabetic Sulphonylureas Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 Eli Lilly
  44. 8.8.1 Eli Lilly Company Information
  45. 8.8.2 Eli Lilly Business Overview
  46. 8.8.3 Eli Lilly Antidiabetic Sulphonylureas Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Eli Lilly Antidiabetic Sulphonylureas Product Portfolio
  48. 8.8.5 Eli Lilly Recent Developments
  49. 8.9 Merck & Co
  50. 8.9.1 Merck & Co Company Information
  51. 8.9.2 Merck & Co Business Overview
  52. 8.9.3 Merck & Co Antidiabetic Sulphonylureas Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Merck & Co Antidiabetic Sulphonylureas Product Portfolio
  54. 8.9.5 Merck & Co Recent Developments
  55. 8.10 Sanofi
  56. 8.10.1 Sanofi Company Information
  57. 8.10.2 Sanofi Business Overview
  58. 8.10.3 Sanofi Antidiabetic Sulphonylureas Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sanofi Antidiabetic Sulphonylureas Product Portfolio
  60. 8.10.5 Sanofi Recent Developments
  61. 8.11 Takeda Pharmaceuticals
  62. 8.11.1 Takeda Pharmaceuticals Company Information
  63. 8.11.2 Takeda Pharmaceuticals Business Overview
  64. 8.11.3 Takeda Pharmaceuticals Antidiabetic Sulphonylureas Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Takeda Pharmaceuticals Antidiabetic Sulphonylureas Product Portfolio
  66. 8.11.5 Takeda Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Antidiabetic Sulphonylureas Value Chain Analysis
  2. 9.1.1 Antidiabetic Sulphonylureas Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Antidiabetic Sulphonylureas Production Mode & Process
  6. 9.2 Antidiabetic Sulphonylureas Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Antidiabetic Sulphonylureas Distributors
  9. 9.2.3 Antidiabetic Sulphonylureas Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst